For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Sorafenib (Nexavar, BAY43-9006) + TACE | Sorafenib was to be orally administered as 2 x 200 mg tablets bid (twice daily). Patients were then also treated with TACE performed with DC Bead (300 to 500 microns) and doxorubicin (150 mg) between 3 to 7 days after the first dose of sorafenib on cycle 1, 3, 7, 13 and then every 6 cycles thereafter (an optional TACE procedure could be performed between Day 1 of Cycle 7 and Cycle 13 and between Day 1 of Cycles 13 and 19, if deemed necessary by the Investigator.) | None | None | 86 | 153 | 150 | 153 | View |
| Placebo + TACE | Placebo was to be orally administered as 2 tablets bid (twice daily). Patients were then also treated with TACE performed with DC Bead (300 to 500 microns) and doxorubicin (150 mg) between 3 to 7 days after the first dose of placebo on cycle 1, 3, 7, 13 and then every 6 cycles thereafter (an optional TACE procedure could be performed between Day 1 of Cycle 7 and Cycle 13 and between Day 1 of Cycles 13 and 19, if deemed necessary by the Investigator.) | None | None | 56 | 151 | 139 | 151 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| BLOOD - OTHER | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI-CTCAE v.3.0 | View |
| EDEMA: LIMB | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI-CTCAE v.3.0 | View |
| HEMOGLOBIN | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI-CTCAE v.3.0 | View |
| LYMPHOPENIA | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI-CTCAE v.3.0 | View |
| PLATELETS | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI-CTCAE v.3.0 | View |
| CARDIAC GENERAL - OTHER | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI-CTCAE v.3.0 | View |
| CARDIAC ISCHEMIA/INFARCTION | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI-CTCAE v.3.0 | View |
| CARDIOPULMONARY ARREST | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI-CTCAE v.3.0 | View |
| HYPERTENSION | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI-CTCAE v.3.0 | View |
| LEFT VENTRICULAR SYSTOLIC DYSFUNCTION | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI-CTCAE v.3.0 | View |
| SUPRAVENTRICULAR ARRHYTHMIA, ATRIAL FIBRILLATION | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI-CTCAE v.3.0 | View |
| DIABETES | NON_SYSTEMATIC_ASSESSMENT | Endocrine disorders | NCI-CTCAE v.3.0 | View |
| ASCITES | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| CONSTIPATION | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| DEHYDRATION | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| DIARRHEA | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| GASTRITIS | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| GI - OTHER | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| HEARTBURN | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| ILEUS | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| LEAK, GI, BILIARY TREE | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| NAUSEA | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| PERFORATION, GI, DUODENUM | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| PERFORATION, GI, GALLBLADDER | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| PERFORATION, GI, STOMACH | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| VOMITING | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| CONSTITUTIONAL SYMPTOMS - OTHER | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| DEATH NOT ASSOCIATED WITH CTCAE TERM, DISEASE PROGRESSION NOS | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| DEATH NOT ASSOCIATED WITH CTCAE TERM, MULTI-ORGAN FAILURE | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| DEATH NOT ASSOCIATED WITH CTCAE TERM, SUDDEN DEATH | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| FATIGUE | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| FEVER | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, ABDOMEN NOS | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, BACK | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, BONE | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, CHEST WALL | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, GALLBLADDER | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, JOINT | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, PLEURA | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, STOMACH | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| SYNDROMES - OTHER | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| CHOLECYSTITIS | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | NCI-CTCAE v.3.0 | View |
| HEPATOBILIARY - OTHER | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | NCI-CTCAE v.3.0 | View |
| LIVER DYSFUNCTION | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | NCI-CTCAE v.3.0 | View |
| PANCREATITIS | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | NCI-CTCAE v.3.0 | View |
| INFECTION (DOCUMENTED CLINICALLY), BLADDER (URINARY) | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION (DOCUMENTED CLINICALLY), BLOOD | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION (DOCUMENTED CLINICALLY), BRONCHUS | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION (DOCUMENTED CLINICALLY), COLON | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION (DOCUMENTED CLINICALLY), LIVER | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION (DOCUMENTED CLINICALLY), LUNG (PNEUMONIA) | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION (DOCUMENTED CLINICALLY), PERITONEAL CAVITY | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION (DOCUMENTED CLINICALLY), SKIN (CELLULITIS) | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION (DOCUMENTED CLINICALLY), UPPER AIRWAY NOS | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION WITH NORMAL ANC, APPENDIX | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION WITH NORMAL ANC, BILIARY TREE | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION WITH NORMAL ANC, BLADDER (URINARY) | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION WITH NORMAL ANC, BLOOD | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION WITH NORMAL ANC, LIVER | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION WITH NORMAL ANC, PERITONEAL CAVITY | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION WITH NORMAL ANC, SKIN (CELLULITIS) | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION WITH NORMAL ANC, URINARY TRACT NOS | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION WITH UNKNOWN ANC, BONE (OSTEOMYELITIS) | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION WITH UNKNOWN ANC, LUNG (PNEUMONIA) | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| INFECTION WITH UNKNOWN ANC, PANCREAS | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI-CTCAE v.3.0 | View |
| ALKALINE PHOSPHATASE | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| ALT | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| AMYLASE | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| AST | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| BILIRUBIN (HYPERBILIRUBINEMIA) | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| CREATININE | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| HYPERGLYCEMIA | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| HYPOGLYCEMIA | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| LIPASE | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| METABOLIC/LAB - OTHER | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| FRACTURE | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI-CTCAE v.3.0 | View |
| JOINT-FUNCTION | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI-CTCAE v.3.0 | View |
| MUSCLE WEAKNESS, LEFT-SIDED | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI-CTCAE v.3.0 | View |
| SECONDARY MALIGNANCY (POSSIBLY RELATED TO CANCER TREATMENT) | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | NCI-CTCAE v.3.0 | View |
| COGNITIVE DISTURBANCE | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI-CTCAE v.3.0 | View |
| CONFUSION | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI-CTCAE v.3.0 | View |
| ENCEPHALOPATHY | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI-CTCAE v.3.0 | View |
| SEIZURE | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI-CTCAE v.3.0 | View |
| OBSTRUCTION, GU, PROSTATE | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI-CTCAE v.3.0 | View |
| RENAL - OTHER | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI-CTCAE v.3.0 | View |
| RENAL FAILURE | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI-CTCAE v.3.0 | View |
| URINARY RETENTION | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI-CTCAE v.3.0 | View |
| ARDS | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI-CTCAE v.3.0 | View |
| DYSPNEA (SHORTNESS OF BREATH) | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI-CTCAE v.3.0 | View |
| PNEUMONITIS | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI-CTCAE v.3.0 | View |
| PULMONARY - OTHER | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI-CTCAE v.3.0 | View |
| RASH/DESQUAMATION | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI-CTCAE v.3.0 | View |
| ULCERATION | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI-CTCAE v.3.0 | View |
| ARTERY INJURY, EXTREMITY - LOWER | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| ARTERY INJURY, OTHER NOS | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE PULMONARY, BRONCHOPULMONARY NOS | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE WITH SURGERY | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE, GI, ABDOMEN NOS | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE, GI, ESOPHAGUS | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE, GI, LIVER | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE, GI, LOWER GI NOS | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE, GI, PERITONEAL CAVITY | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE, GI, RECTUM | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE, GI, STOMACH | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE, GI, UPPER GI NOS | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE, GI, VARICES (ESOPHAGEAL) | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE, GI, VARICES (RECTAL) | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| PERIPHERAL ARTERIAL ISCHEMIA | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| THROMBOSIS/THROMBUS/EMBOLISM | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| VASCULAR - OTHER | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| VISCERAL ARTERIAL ISCHEMIA | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| EDEMA: LIMB | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI-CTCAE v.3.0 | View |
| HEMOGLOBIN | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI-CTCAE v.3.0 | View |
| PLATELETS | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI-CTCAE v.3.0 | View |
| HYPERTENSION | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI-CTCAE v.3.0 | View |
| DIABETES | NON_SYSTEMATIC_ASSESSMENT | Endocrine disorders | NCI-CTCAE v.3.0 | View |
| ANOREXIA | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| ASCITES | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| CONSTIPATION | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| DIARRHEA | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| DISTENSION | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| GASTRITIS | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| GI - OTHER | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| HEARTBURN | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| MUCOSITIS (FUNCTIONAL/SYMPTOMATIC), ORAL CAVITY | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| VOMITING | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| FATIGUE | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| FEVER | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| FLU-LIKE SYNDROME | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| INSOMNIA | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, ABDOMEN NOS | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, BACK | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, CHEST/THORAX NOS | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, EXTREMITY-LIMB | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, HEAD/HEADACHE | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, JOINT | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, LIVER | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, MUSCLE | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| PAIN, STOMACH | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| RIGORS/CHILLS | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| WEIGHT LOSS | NON_SYSTEMATIC_ASSESSMENT | General disorders | NCI-CTCAE v.3.0 | View |
| BILIRUBIN (HYPERBILIRUBINEMIA) | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| HYPERGLYCEMIA | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| HYPOALBUMINEMIA | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| HYPOKALEMIA | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| HYPOPHOSPHATEMIA | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| LIPASE | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| METABOLIC/LAB - OTHER | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| DIZZINESS | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI-CTCAE v.3.0 | View |
| MOOD ALTERATION, ANXIETY | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI-CTCAE v.3.0 | View |
| URINARY FREQUENCY | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI-CTCAE v.3.0 | View |
| COUGH | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI-CTCAE v.3.0 | View |
| RASH/DESQUAMATION | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI-CTCAE v.3.0 | View |
| HEMORRHAGE PULMONARY, NOSE | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI-CTCAE v.3.0 | View |
| NAUSEA | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI-CTCAE v.3.0 | View |
| ALT | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| AMYLASE | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| AST | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI-CTCAE v.3.0 | View |
| DYSPNEA (SHORTNESS OF BREATH) | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI-CTCAE v.3.0 | View |
| VOICE CHANGES | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI-CTCAE v.3.0 | View |
| ALOPECIA | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI-CTCAE v.3.0 | View |
| DERMATOLOGY - OTHER | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI-CTCAE v.3.0 | View |
| DRY SKIN | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI-CTCAE v.3.0 | View |
| HAND-FOOT SKIN REACTION | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI-CTCAE v.3.0 | View |
| PRURITUS | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI-CTCAE v.3.0 | View |